Wealth

Gannett Co, a mass media holding company, released its financial results for the third quarter (Q3) ending September 30, 2023, today, revealing a 9.1% decrease

Acurx Pharmaceuticals, a clinical-stage biopharmaceutical company at the forefront of developing a groundbreaking class of small molecule antibiotics targeting resilient bacterial infections, unveiled promising efficacy

In a major blow to Outlook Therapeutics, stock of the biopharmaceutical company plummeted by more than 50% in premarket trading on Thursday. The sharp decline

Nikola Corporation, a prominent player in the global zero-emissions transportation and energy sector, unveiled its financial results for the third quarter (Q3) of 2023. Despite

Panbela Therapeutics, a clinical stage biopharmaceutical company at the forefront of developing disruptive therapeutics for patients facing urgent unmet medical needs, has unveiled groundbreaking preclinical